PeoSoc PeoSoc
  • affected Indigenous Peoples
  • Trump administration
  • ProPublica
  • ensure Indigenous Peoples
  • academic appointment
  • Aboriginal Peoples
  • Positive News
  • Pharmaceuticals


    FDA’s Foreign Drug Oversight: Safety Concerns & Exemptions Exposed

    FDA’s Foreign Drug Oversight: Safety Concerns & Exemptions Exposed

    ProPublica investigation reveals FDA's oversight lapses on foreign drugmakers, raising concerns about unsafe medications entering the U.S. via exemptions. Legislators demand answers on drug safety and accountability.


    FDA Cuts Jeopardize Drug Safety: ProPublica Investigation

    FDA Cuts Jeopardize Drug Safety: ProPublica Investigation

    FDA staff cuts impacting crucial international drug factory inspections, potentially jeopardizing the safety of medications used by millions. ProPublica reveals safety concerns and staff depletion.


    FDA’s Secret Drug Loophole: Banned Factories Supply US

    FDA’s Secret Drug Loophole: Banned Factories Supply US

    ProPublica reveals FDA's loophole allowing over 150 drugs from banned factories with mold/filth to enter the US, raising safety concerns and potential patient harm.


    US Drug Prices: Bipartisan Bill Targets High Costs

    US Drug Prices: Bipartisan Bill Targets High Costs

    A bipartisan bill aims to penalize US medicine firms charging higher prices than other rich nations. Revlimid's price disparity highlights the issue. The debate involves research costs and government intervention.